North America Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook

Name: North America Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The viral vector and plasmid dna manufacturing market in North America is expected to reach a projected revenue of US$ 9,538.3 million by 2033. A compound annual growth rate of 14.5% is expected of North America viral vector and plasmid dna manufacturing market from 2026 to 2033.

Biotechnology
- Recombinant DNA & DNA Analysis
  - Viral Vector And Plasmid DNA Manufacturing Market Outlook

North America viral vector and plasmid dna manufacturing vector type outlook (Revenue, USD million, 2021-2033)
- Adeno-associated virus (AAV)
- Lentivirus
- Adenovirus
- Retrovirus
- Plasmids
- Others
North America viral vector and plasmid dna manufacturing workflow outlook (Revenue, USD million, 2021-2033)
- Upstream Processing
  - Vector Amplification & Expansion
  - Vector Recovery/Harvesting
- Downstream Processing
  - Purification
  - Fill-finish
North America viral vector and plasmid dna manufacturing application outlook (Revenue, USD million, 2021-2033)
- Antisense & RNAi
- Gene Therapy
- Cell Therapy
- Vaccinology
- Research Applications
North America viral vector and plasmid dna manufacturing end-use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
North America viral vector and plasmid dna manufacturing disease outlook (Revenue, USD million, 2021-2033)
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others

North America Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!